Difficulty: Medium
Average Score: 94%
Practice
This drug is a desintoxicative plasma substitute:
Correct answer
B
Rationale
In the context of pharmacology across the lifespan, understanding the use of different intravenous solutions and plasma substitutes is crucial. In this question, the correct answer is B) Haemodesum. Haemodesum is a desintoxicative plasma substitute that is used to expand plasma volume in cases of hypovolemia, shock, or during surgical procedures. It contains essential electrolytes and proteins that help in maintaining oncotic pressure and supporting vital physiological functions.
Option A) Polyglucinum is a colloidal plasma substitute that contains dextran and electrolytes. While it can be used as a volume expander, it is not specifically classified as a desintoxicative plasma substitute like Haemodesum.
Option C) Sodium chloride isotonic for injections is a simple saline solution that is used to restore electrolyte balance and hydration but does not serve as a plasma substitute like Haemodesum.
Option D) Disolum and Trisolum are not recognized as desintoxicative plasma substitutes. They are not commonly used in clinical practice for plasma volume expansion or detoxification purposes.
Educationally, this question highlights the importance of understanding the characteristics and indications of different intravenous solutions and plasma substitutes for effective pharmacological management across different patient populations and clinical scenarios. It reinforces the need for healthcare professionals to select the most appropriate solution based on the patient's condition and treatment goals.
Option A) Polyglucinum is a colloidal plasma substitute that contains dextran and electrolytes. While it can be used as a volume expander, it is not specifically classified as a desintoxicative plasma substitute like Haemodesum.
Option C) Sodium chloride isotonic for injections is a simple saline solution that is used to restore electrolyte balance and hydration but does not serve as a plasma substitute like Haemodesum.
Option D) Disolum and Trisolum are not recognized as desintoxicative plasma substitutes. They are not commonly used in clinical practice for plasma volume expansion or detoxification purposes.
Educationally, this question highlights the importance of understanding the characteristics and indications of different intravenous solutions and plasma substitutes for effective pharmacological management across different patient populations and clinical scenarios. It reinforces the need for healthcare professionals to select the most appropriate solution based on the patient's condition and treatment goals.